Volume 78, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


We examined whether live attenuated Japanese encephalitis (JE) vaccine is effective in preventing West Nile virus (WNV) infection in the People’s Republic of China. Three groups were recruited into the study: patients with Japanese encephalitis (JE), healthy controls vaccinated with live attenuated 2 SA14-14-vaccine against JE virus (JEV), and unvaccinated healthy controls. Serum samples were collected and screened for IgG antibodies against JEV by an indirect immunofluorescence assay. Positive samples were then analyzed for levels of antibodies against JEV and neutralizing antibodies against West Nile virus (WNV) by a plaque-reduction neutralization test (PRNT). Although most persons had medium to high levels of JEV-reactive IgG and neutralizing antibodies, only 2 of the 82 unvaccinated control samples were positive for the WNV-reactive antibodies. These findings suggest that previous JEV infection or vaccination did not induce adequate levels of WNV-reactive antibodies in the population studied. However, how these persons would respond to a secondary flavivirus infection and whether their prior experience with wild-type or attenuated JE vaccine will provide some cross-protection against WNV disease still warrants further investigation.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Gubler DJ, 2007. The continuing spread of West Nile virus in the western hemisphere. Clin Infect Dis 45 : 1039–1046.
    [Google Scholar]
  2. Goverdhan MK, Kulkarni AB, Gupta AK, Tupe CD, Rodrigues JJ, 1992. Two-way cross-protection between West Nile and Japanese encephalitis viruses in bonnet macaques. Acta Virol 36 : 277–283.
    [Google Scholar]
  3. Ilkal MA, Prasanna Y, Jacob PG, Geevarchese G, Banerjee K, 1994. Experimental studies on the susceptibility of domestic pigs to West Nile virus followed by Japanese encephalitis virus infection and vice versa. Acta Virol 38 : 157–161.
    [Google Scholar]
  4. Tesh RB, Travassos da Rosa AP, Guzman H, Araujo TP, Xiao SY, 2002. Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis. Emerg Infect Dis 8 : 245–251.
    [Google Scholar]
  5. Kanesa-Thasan N, Putnak JR, Mangiafico JA, Saluzzo JE, Ludwig GV, 2002. Short report: absence of protective neutralizing antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines. Am J Trop Med Hyg 66 : 115–116.
    [Google Scholar]
  6. Yamshchikov G, Borisevich V, Kwok CW, Nistler R, Kohlmeie J, Seregin A, Chaporgina E, Benedict S, Yamshchikov V, 2005. The suitability of yellow fever and Japanese encephalitis vaccines for immunization against West Nile virus. Vaccine 23 : 4785–4792.
    [Google Scholar]
  7. Johnson BW, Kosoyo O, Martin DA, Noga BJ, Russell BJ, Jonson AA, Petersen LR, 2005. West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese Encephalitis viruses. Vector Borne Zoonotic Dis 5 : 137–145.
    [Google Scholar]
  8. Hoke CH, Nisalak A, Sangawhipa N, Jatansen S, Laorakapongse T, Innis BL, Kotchasenee S, Gingrich JB, Latendresse J, Fukai K, 1988. Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 319 : 608–614.
    [Google Scholar]
  9. Endy TP, Nisalak A, Chunsuttitwat S, Vaughn DW, Green S, Ennis FA, Rothman AL, Libraty DH, 2004. The relationship of pre-existing dengue virus neutralizing antibody levels to viremia and disease severity in a prospective cohort study of dengue in Thailand. J Infect Dis 189 : 990–1000.
    [Google Scholar]

Data & Media loading...

  • Received : 13 May 2007
  • Accepted : 18 Mar 2008
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error